Volume 1 – Number 3

Origin and Evolution of Human and Simian T-Cell Lymphotropic Viruses

Mitochondrial Toxicity of Nucleoside Analogue Reverse Trancriptase Inhibitors: Lactic Acidosis, Risk Factors and Therapeutic Options

Heterogeneity in the Response to Antiretroviral Therapy

HIV Drug Resistance and Insufficient Drug Plasma Levels as Factors Determining Antiretroviral Treatment Failure

Clinical Pharmacokinetics of Antiretroviral Drugs

Discontinuation of Prophylaxis Against Opportunistic Infections in HIV-Infected Persons Receiving Potent Combination Antiretroviral Therapy

Pig Retroviruses and Xenotransplantation – A Key Safety Question Answered?

Emergence of AZT Resistance Taking d4T

Attenuated HIV Vaccines

Promising New Inhibitors of HIV Coreceptors